Clinical and Microbiological Effects of 2/5% Acyclovir Gel
Phase 3
- Conditions
- chronic periodontitis.Chronic periodontitis
- Registration Number
- IRCT138801231809N1
- Lead Sponsor
- Dental School, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Presence of chronic periodontitis, presence of at least 2 pockets with 5 mm pocket depth
Exclusion criteria: Presence of any systemic disease, periodontal treatment during 6 month prior to study, antibiotic use during 3 months prior to study, Smoking, Pregnancy, or breast feeding
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method P. Gingivalis Count. Timepoint: Baseline (Before Treatment), 1 & 3 months after treatment. Method of measurement: Mycrobiological Analysis ( Culture & PCR).;Clinical Attachment Level. Timepoint: Baseline (Before Treatment), 1 & 3 month after treatment. Method of measurement: Clinical Evaluations.;Pocket Depth. Timepoint: Baseline (Before Treatment), 1 & 3 months after treatment. Method of measurement: Clinical Evaluations (Probing).;Gingival Index. Timepoint: Baseline (Before Treatment), 1 & 3 month after treatment. Method of measurement: Clinical Evaluations.;Bleeding On Probing. Timepoint: Baseline (Before Treatment), 1 & 3 month after treatment. Method of measurement: Clinical Evaluations.
- Secondary Outcome Measures
Name Time Method